#q2 earnings
15 stories
IIFL Finance Q2 Profit Doubles
IIFL Finance's Q2 profit nearly doubles to Rs 805 crore as AUM grows 38%.
The Economic Times · 1m

Motilal Oswal names 40 stocks for Q2 earnings season
Motilal Oswal recommends 40 stocks to buy as Indian equities show improved risk-reward profile.
mint · 1m

GoDaddy Shares Jump 5.0% Post Q2 Earnings
GoDaddy stock rises 5.0% after Q2 earnings analysis sparks investor debate.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m

Nifty 50, Sensex, Bank Nifty Weekly Outlook
Nifty 50 ends 8-week losing streak but faces key resistance levels this week.
mint · 2m

Indian Stock Market Relief Rally
Indian stock market ends weekly losing streak after relief rally.
mint · 1m
Stocks Plunge as RBI Tightens Policy
RBI policy shifts trigger sharp stock market drop in India.
The Economic Times · 1m

Bristol-Myers Squibb Stock: Growth Opportunity
Bristol-Myers Squibb's strong Q2 earnings and dividend offer a pullback opportunity.
Seekingalpha · 1m
Indian IT Q2 Earnings Dilemma Deepens
AI pressures weaken Indian IT growth as pricing power falls.
The Economic Times · 1m

IT Stocks Picks After Accenture Q4 Beat
Choice Broking recommends TCS, Tech Mahindra, Coforge, and Mphasis for Indian IT investors ahead of Q2 earnings.
mint · 1m
IT Q2 Preview: Muted Growth, Steady Margins
IT firms report muted Q2 growth as AI deflation pressures margins.
The Economic Times · 1m
Foreign Investors Return to Indian Stock Market
Five factors needed for foreign investors to return to Indian equities.
The Economic Times · 1m
Stock Market Plunges as FII Outflows and Bond Yields Spook Investors
Indian stock market crashes after FII outflows and bond yields hit multi-year highs.
The Economic Times · 1m
Meta Adds $200 Billion in One Day with AI App
Meta's new AI app beat ChatGPT's launch, adding $200 billion in market value overnight.
24/7 Wall St. · 1m

Innate Pharma Q2 Earnings Highlights
Innate Pharma secures $75m Sobi deal for cancer drug.
Yahoo Finance · 1m

CVS Shares Trade Below Wall Street Targets
CVS Health stock trades near $94, 19% below analyst target and 50% below model's $141 base case
Yahoo Finance · 1m